| Active substance | difelikefalin |
| Holder | Vifor Fresenius Medical Care Pharma Ltd |
| Status | closed |
| Indication | treatment of moderate to severe chronic kidney disease-associated pruritus (CKD-aP) in adults undergoing hemodialysis (HD) |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent | |
| Last update | 30/01/2024 |